AI Insight
A large-scale study has confirmed that SARS-CoV-2 infection can reactivate dormant viruses already present in the body, such as Epstein-Barr virus and other herpesviruses. These viral reactivations may contribute to worsening acute COVID-19 symptoms and potentially increase the risk of developing Long Covid. The research provides evidence for a mechanism by which COVID-19 infection can trigger secondary complications beyond the direct effects of SARS-CoV-2.
Why it matters
This finding could explain why some COVID-19 patients experience more severe symptoms or prolonged recovery periods. Understanding viral reactivation as a contributing factor to Long Covid may lead to new treatment approaches targeting these dormant viruses alongside COVID-19 management.
Understand the Science
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid
Source: COVID-19 can wake up dormant viruses in the body, large study confirms